İsteğe bağlı ürün analizi
İzninizle, hangi araştırma yolculuklarının işe yaradığını anlamak için gizliliği gözeten sınırlı analizler kullanırız. Reklam izleyicileri veya oturum kaydı kullanmayız. Bu seçimi Tercihler bölümünden değiştirebilirsiniz. Okuyun Gizlilik Politikası.
McCormick & Company Incorporated's published Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $13.1B | |
|---|---|---|
| Revenue (ttm) | 7.7B | |
| Net income (ttm) | 1.5B | |
| EPS (ttm) | $5.53 | |
| Shares out | 269.1M | |
| P/E (trailing) | 8.3x | |
| P/E (forward) | 14.2x | |
| Dividend | $1.92 (4.19%) | |
| Volume | 3,490,079 | |
| Beta | 0.64 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | 2025-11-30 | Trend |
| Revenue | $6.32B | $6.35B | $6.66B | $6.72B | $6.84B | +2.0% |
| Gross profit | $2.49B | $2.27B | $2.50B | $2.59B | $2.59B | +1.0% |
| Operating income | $1.02B | $863.6M | $963.0M | $1.06B | $1.07B | +1.3% |
| Net income | $755.3M | $682.0M | $680.6M | $788.5M | $789.4M | +1.1% |
| EPS (diluted) | $2.80 | $2.52 | $2.52 | $2.92 | $2.93 | +1.1% |
| EBITDA | $1.22B | $1.16B | $963.0M | $1.32B | $1.34B | +2.4% |
| R&D | $87.3M | $87.5M | $94.9M | $102.9M | $106.1M | +5.0% |
| SG&A | $1.40B | $1.36B | $1.48B | $1.52B | $1.50B | +1.7% |
Recent company headlines from major financial publishers.
The base path expects steady compound growth driven by essential consumer seasoning demand and ongoing B2B flavor development partnerships. Disconfirmation would appear by mid-FY2027 if retail promotional pressure erodes shelf leadership or key retail partners demand pricing concessions.
The bull path reflects accelerated geographic expansion across EMEA and Asia Pacific, accompanied by premium brand mix shift and faster food service volume recovery. Disconfirmation would emerge if international sales decelerate or custom flavor contracts fail to expand product lines by late FY2027.
| Ke ↓ / g → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 4.9% | $69.5 | $76.0 | $84.9 | $98.0 | $120 |
| 5.9% | $58.5 | $62.1 | $66.8 | $72.9 | $81.4 |
| 6.9% | $51.2 | $53.5 | $57.6 | $59.8 | $64.2 |
| 7.9% | $45.9 | $47.5 | $49.3 | $51.5 | $54.2 |
| 8.9% | $41.9 | $43.0 | $44.3 | $45.8 | $47.6 |
Upcoming earnings date and setup when available.
Her ay yayımlanan araştırma sürümünün taşıdığı derecelendirme. Bir derecelendirme, analiz tarihindeki fiyatı gerçeğe uygun değerle karşılaştırır; tahminin doğru çıkıp çıkmadığının kaydı değildir.
| Yıl | Oca | Şub | Mar | Nis | May | Haz | Tem | Ağu | Eyl | Eki | Kas | Ara |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |